Centre Expects Anti-Cancer Drug Prices to Fall 20-70 per Cent Under Proposed Trade Margin Cap
6 Articles
6 Articles
Centre expects anti-cancer drug prices to fall 20-70 per cent under proposed trade margin cap - tennews.in: National News Portal
New Delhi, Oct 23 (IANS) The Centre has told the Supreme Court that capping trade margins on anti-cancer medicines at 30 per cent of their maximum retail price (MRP) is expected to save patients around Rs 2,500 crore annually, with the proposed measure likely to reduce the MRP of such drugs by 20 to 70 […] The post Centre expects anti-cancer drug prices to fall 20-70 per cent under proposed trade margin cap appeared first on tennews.in: National…
Centre expects anti-cancer drug prices to fall 20-70 per cent under proposed trade margin cap
Digital Desk | New Delhi, Oct 23 (IANS) The Centre has told the Supreme Court that capping trade margins on anti-cancer medicines at 30 per cent of their maximum retail price (MRP) is expected to save patients around Rs 2,500 crore annually, with the proposed measure likely to reduce the MRP of such drugs by 20 to 70 per cent. In an affidavit filed before the apex court in a pending plea seeking regulation of medicine prices, the Union governm…
New Delhi, Oct. 23 (IANS) The Central Government has filed an affidavit in the Supreme Court regarding drug prices. In the affidavit, the Central Government stated that it has decided to limit the trade margin on non-scheduled cancer drugs to 30 percent of the MRP (maximum retail price). The government has constituted an expert committee to prepare a list of cancer treatment drugs for which this provision can be implemented. On October 9, 2026, …
Modi Government on Cancer Medicines: Cancer medicines are likely to become cheaper soon. The Modi government has submitted an affidavit in the Supreme Court. It has given information about an important decision. This may reduce the cost of cancer medicines in the coming days.
The Central Government is preparing to reduce the prices of expensive cancer medicines.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium








